Attitudes toward diabetes affect maintenance of drug-free remission in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion treatment.

Furthermore, HOMA-IR at baseline increased per 1.0 reduced the risk of relapse by 14.6% with borderline significance, and every 1 mmol/L increment of PPG after CSII increased relapse risk by 15.6% ( Table 3 ).

also in 7,017 other papers

HOMA-IR in the remission group was higher, with marginal significance before treatment, but was not different from that of the nonremission group after CSII was suspended.

also in 5,069 other papers